272BIO

272BIO

Foundation date

2019

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Biosimilars
• #Therapeutics - Proteins

Therapeutic areas

• #Digestive system
• #Diseases of the ear
• #Diseases of the eye
• #Diseases of the nervous system
• #Endocrine - nutritional and metabolic diseases
• #Neoplasms / cancer / oncology
• #Respiratory system
• #Skin and subcutaneous tissue

Animal Health

Pharmaceutical

272BIO is a specialist biotechnology company which focuses on developing novel biological therapies for veterinary disease areas. 272BIO is developing biotherapeutics, using innovative technologies, for livestock and companion animal disorders.
We are bringing cutting-edge biotherapeutic technology and platforms to the animal health arena. Applying novel technologies, 272BIO is able to reduce hitherto prohibitive production costs and produce affordable therapies.